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Interactions between human monocytes and tumour cells. Monocytes can
either enhance or inhibit the growth and survival of K562 cells
B. Davies* & S.W. Edwards
Department ofBiochemistry, University ofLiverpool, PO Box 147, Liverpool L69 3BX, UK.
Summary Human bloodstream monocytes can kill cultured tumour cells (K562), as assessed by specific
release of 5"Cr from the targets and by inhibition of 3H-thymidine incorporation. Confluent monolayers of
monocytes were required for maximal cytotoxicity, and the density of the K562 cells was also an important
factor. For example, when K562 cells were seeded at high cell densities, they were killed during incubation
with monocytes, but when seeded at low cell densities their growth and survival was enhanced during culture
with monocytes. The factor(s) which promoted the survival and division of low density K562 cultures was
endogenously secreted from monocytes as it was present in monocyte-conditioned medium, whereas the
cytotoxic factor(s) were only expressed during co-culture of monocytes with K562 cells. Conditioned medium
from HL 60, U-937, HeLa and K562 could also enhance the growth and survival of low density K562
cultures, and a similar effect was also observed upon the addition ofcatalase and superoxide dismutase to such
cultures. Thus, the monocyte:target ratio is important in determining whether monocytes exhibit cytotoxic or
growth-promoting effects and hence tumour-derived or monocyte-derived reactive oxidant species may play a
role in tumour cell cycle regulation.
Monocytes are capable of producing reactive oxygen
intermediates such as 02-, H202, 0OH and HOCI via the
activities of the NADPH oxidase and myeloperoxidase.
These species are damaging to biological molecules and are
involved in the killing of certain microorganisms by neutro-
phils (Edwards et al., 1987; Holmes et al., 1967). There is
also indirect evidence to suggest that reactive oxygen
intermediates are important for the killing of tumour cells by
mononuclear phagocytes: (1) myeloperoxidase-deficient indi-
viduals have higher incidences of neoplasms compared to
normal individuals (Lanza et al., 1987); (2) a cell-free
myeloperoxidase-H202-halide system can kill tumour cells in
vitro (Klebanoff & Clark, 1978); (3) treatments which in-
crease the tumouricidal competence of murine macrophages
(for example, y-interferon) often also increase the capacity of
the cells to generate reactive oxidants (Reed et al., 1987;
Nathan et al., 1984); (4) BCG-elicited peritoneal macro-
phages have a greater respiratory burst in response to phor-
bol myristate acetate (PMA) and exert greater tumour
cytotoxicity than thioglycollate-elicited macrophages (Drath,
1985); (5) the specificity of mononuclear cytotoxicity to only
tumour cells (and not to normal cells) may be explained by
the fact that many tumour cell lines have lower than normal
levels of enzymes (e.g. superoxide dismutase (SOD), catalase,
glutathione peroxidase) associated with combating oxidative
stress (Sun et al., 1989).
The tumouricidal activity of monocytes can be manipu-
lated in vitro and presumably in vivo by exposure to factors
such as v-interferon and lipopolysaccharide (LPS) (Hibbs et
al., 1977; Russell et al., 1977) and it is also recognised that,
depending upon their past history, these cells can display an
enormous variation in their tumouricidal potency. Fre-
quently, macrophages isolated from tumours are not spon-
taneously cytotoxic (Loveless & Heppner, 1983; Yamamura
et al., 1984) and in situ hybridisation studies have revealed
that only a few per cent of TAM express tumour necrosis
factor (Taylor et al., 1990). There is also a growing
awareness that monocytes may also assist in the promotion
of tumour cell growth. For example, tumours grow more
slowly in mice which have been depleted of monocytes than
in control animals (Inoue & Nelson, 1984), and monocytes
may stimulate tumour growth both in vivo and in vitro
(Currie, 1981; Kadhim & Rees, 1984; Gorelick et al., 1985).
TAM are derived from bloodstream monocytes which have
been attracted to infiltrate the tumour and thus are likely to
have been exposed to agents which will alter their cytotoxic
potential. There are several factors which are important in
regulating the activity of TAM, namely (a) the cytotoxic
activity of bloodstream monocytes, (b) the local factors to
which they are exposed either during recruitment or within
the tumour and (c) the local conditions (e.g. 02 tensions)
within the tumour. The aim of the present study, therefore,
was to establish the interactions between human bloodstream
monocytes and cultured tumour cells which result in cyto-
toxicity. We show that freshly-isolated bloodstream
monocytes exhibit considerable cytotoxicity towards tumour
cells. Furthermore, monocytes secrete a factor(s) which is
capable of enhancing the growth and viability of tumour cells
seeded at low cell densities and this factor(s) may be an
anti-oxidant.
Materials and methods
Growth and maintenance ofcultured cell lines
The cell lines used in this study were maintained at 37°C in
RPMI 1640 supplemented with HEPES (20 mM), heat inacti-
vated foetal calf serum (10%), penicillin (50 IU ml-'), strep-
tomycin (50tLg ml-') and glutamine (2 mM) in a humidified
atmosphere of 5% CO2 and 95% air. K562, U937, HeLa and
HL 60 cells were obtained from the European Collection of
Animal Cell Cultures, Porton Down, Salisbury, UK K562,
U937 and HL 60 cells were grown in suspension and main-
tained at between 3-9 x I05cells ml-' at all times. These
cells were passaged (usually every 2-3 days) by suspending in
fresh medium after centrifugation at 600 g for 4 min. HeLa
cells were grown as an adherent monolayers: before passage
these cells were washed with phosphate buffered saline (PBS:
0.9% NaCl; 10 mM KH2PO4, pH 7.4) and then treated with
trypsin and EDTA for approximately 2 min until the cells
began to detach. The cells were then washed, resuspended in
fresh tissue culture medium and seeded into new flasks at a
density of 2 x I05 cells ml-'.
Purification ofmonocytesfrom peripheral blood
One vol 2.7% w/v EDTA (pH 7.4) was added to 9 vol
heparinised blood (from healthy volunteers) in a 30 ml
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universal tube and to 9 vol of this 1 vol 6% Dextran in PBS
pH 7.4 was added. After approximately 15 min the upper
layer of leukocyte-rich plasma was removed. Six ml of this
was layered over 3 ml of Nycodenz-M solution (density of
1.077 ± 0.001 g ml-') in 15 ml conical-bottomed poly-
propylene centrifuge tubes and centrifuged at 600 g
(2,200 rev min-') for 15 min. The clear yellow plasma was
removed from the top of the tube and retained. The rest of
the plasma was removed to within 4 mm of the interface and
discarded. The remainder of the liquid (containing monocytes
and platelets) was removed to just above the pellet (contain-
ing lymphocytes and erythrocytes) and washed in an equal
volume of PBS pH 7.4, supplemented with 3.1 mM EDTA
and 1% v/v foetal calf serum by centrifuging for 5 min at
600g (2,200 rev min- ). The pellet (containing monocytes
and large numbers of platelets) was washed once more and
suspended in 1 ml of the above medium. This was then
layered onto 3 ml of the retained clear plasma and centri-
fuged at 50g (500 rev min -) for 15 min: after this procedure
the platelets were retained in the supernatant and were dis-
carded, whilst the pellet containing monocytes was retained.
The monocyte pellet was washed in PBS pH 7.4, supp-
lemented with 3.1 mM EDTA and 1% (v/v) foetal calf serum
and then suspended in tissue culture medium (RPMI 1640
supplemented with HEPES, 20 mM; heat inactivated foetal
calf serum, 10%; penicillin, 50 IU ml-', streptomycin,
50figml-'; glutamine, 2 mM) and an aliquot was removed
for cell counting. Monocyte preparations were >95% pure
as assessed by esterase/Meyer's haematoxylin staining and
yields were 6.1 (± 1.5) x 106 monocytes/60 ml blood
(n = 30).
5'Cr-Release cytotoxicity assay
The method employed was a modification of that described
previously (Russell, 1981). Approximately 1 x 106 K562 cells
were suspended in 5 ml of culture medium to which was
added to 250pCi 5'Cr (as stock sodium chromate lmCi ml-';
the specific activity varied between 250-500 mCi mg-'
chromium). The cells were incubated with label at 37°C for
1 h and then washed in 30 ml of warm culture medium. The
cells were then incubated for 1 h at 37°C in 10 ml of culture
medium, during which period dead and damaged cells release
label. After washing once more in 30 ml of warm culture
medium the cells were finally resuspended in a suitable
volume of culture medium and added immediately to micro-
titre plate wells containing monocytes (adherent to microtitre
plates) or culture medium alone. After culture for 16 h,
100jil of culture supernatant was removed (from a total of
200;p1) from each well, care being taken not to disturb the
cells at the bottom of the well, and transferred to a counting
vial. Samples were counted for 2 min using an LKB
Minigamma 1275 y-counter. Cytotoxicity was calculated as
% specific release as follows:
% Specific Release =
Experimental Release-Spontaneous Release
Total Release-Spontaneous Release
x 100
where: Spontaneous Release = CPM released from K562 cells
cultured alone; Experimental Release = CPM released from
K562 cells co-cultured with monocytes and Total Release =
Total CPM in K562 cells (released by 0.1% Triton X-100).
Each measurement was performed in triplicate and the
mean ± standard deviation of the spontaneous, experimental
and total release were calculated for each set of conditions.
Measurement ofIncorporation of3H-thymidine by K562 cells
The method used was adapted from that described in (Kap-
lan, 1981). 0.5 JLCi 3H-thymidine was added to each micro-
titre plate well containing K562 cells (either cultured alone or
co-cultured with monocytes adherent to microtitre plates) in
200 p1 of culture medium. After 2 h incubation at 37°C, the
contents of the cells were aspirated, taking care to remove all
cells (this was confirmed by viewing the wells microscopic-
ally), and placed in 2 ml of 10% trichloracetic acid (TCA).
This mixture was mixed vigorously and diluted to 10ml of
10% TCA, filtered (under vacuum) with GF-C filters which
were then washed with a further 10 ml of 10% TCA with
remove any unincorporated label. Finally, the filter was
washed in ethanol (to assist drying) and dried at 60°C for
4 h. Each filter was placed in 3.5 ml Scintran Cocktail T
scintillation fluid and the incorated label quantitated by
counting the filter using the 3H-channel of a scintillation
counter for 2 min. Binding of unincorporated 3H-thymidine
to filters could not be detected above background levels. For
each set of conditions the measurements were made in trip-
licate and the means ± standard deviation were calculated.
Reagents
RPMI, Foetal calf serum, glutamine, penicillin/streptomycin
were from Flow Laboratories whilst Nycodenz-M was from
Nycomed AS (Norway). Superoxide dismutase and catalase
were from Boehringer whilst 3H-thymidine and "Cr (as
sodium chromate) were from Amersham.
Results
Effect ofmonocyte density and age on cytoxocity
Before monocyte cytotoxicity could be investigated in vitro, it
was first necessary to establish the optimal experimental con-
ditions to detect tumour cell lysis. Thus, we determined the
kinetics of both spontaneous and monocyte-dependent
release of 5'Cr from pre-loaded tumour cells. When 5'Cr
loaded K562 cells were incubated in the absence of
monocytes, release of this label was undetectable over the
first 5 h in culture: after this time 5'Cr release was observed
and this progressively increased over the following 17 h
(Figure la). When K562 cells were co-cultured with freshly-
isolated bloodstream monocytes, release of 5'Cr was detected
after 5 h incubation, and from 7-18 h culture monocyte-
dependent release was considerably greater than spontaneous
release. When the specific (i.e. monocyte-dependent) release
of 5'Cr from K562 cells was calculated (Figure lb) clear and
reproducible monocyte-dependent cytotoxicity was
measurable after incubation for 16-22 h. Thus, in all subse-
quent experiments, monocyte cytotoxicity was determined
after 16 h culture with tumour cells.
It was then necessary to determine the optimal monocyte:
tumour ratio required for killing. This was initially achieved
by adding varying numbers of monocytes to U-shaped wells
of 96 well microtitre plate and adding 6 x 104 of 5'Cr-loaded
K562 cells (in a total volume of 200 ll). After 16 h incuba-
tion the specific (monocyte-dependent) release of 5'Cr was
determined. Figure 2 shows that when the monocyte number
per well was <5 x 104 no cytotoxicity was observed, but as
monocyte numbers increased up to 2 x i05 per well, so
specific release of 5'Cr occurred: at monocyte numbers in
excess of this, no enhancement was observed and this was
because microscopic examination revealed that 2 x i05
monocyte per well, the monocytes were confluent at the base
of the well. The mean value of cytotoxicity of monocytes
from different donors (under conditions of 6 x 104 K562:
2 x i05 monocytes in 200J1), as assessed by % specific
release was 30% (SD ± 22%; n = 12).
Effect ofK562 cell densitiy on monocyte cytotoxicity
When cultured alone, 5'Cr loaded K562 cells seeded at low
cell density (1 x 104cells per well) released relatively large
amounts of 5'Cr (620 ± 16 c.p.m./104 cells) after 16 h in cul-
ture (Figure 3a). This release decreased as the seeding density
increased so that at seeding densities between 6-8 x 104 per
well, < 150 c.p.m. 10-4 cells were released. When monocytes
were added to wells containing >3 x 104 K562 cells
(tumour:monocyte ratio of 1:7), the rate of 5'Cr releaseINTERACTIONS BETWEEN HUMAN MONOCYTES AND TUMOUR CELLS
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Figure 1 Time course of release of 5"Cr-sodium chromate from
K562 in the presence and absence of monocytes. 2 x 105 mono-
cytes (freshly isolated from blood by the Nycodenz method) were
seeded into U-shaped wells of a microtitre plate in 200 ld of
culture medium and left for 1 h until the cells had settled to the
bottom of the well. This was defined as time zero. At this time
6 x 10' K562 cells which had been pre-loaded with 5"Cr were
added to each well and to corresponding control wells containing
no monocytes. At various time intervals the release of 5'Cr from
both monocyte-containing (0) and control (@) wells was deter-
mined by the procedure described in Materials and methods.
Each measurement was made in triplicate and the mean plotted
in a, error bars showing the standard deviation of the
measurements. The % specific release and its standard deviation
were then calculated and plotted in b. The results shown are
typical of five identical experiments performed with monocytes
from five different donors.
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Figure 2 The effect of monocyte monolayer density on cytotoxi-
city. Experimental conditions were as described in the legend to
Figure 1 except that varying numbers of monocytes were added
(in 200 il of medium) to wells. Following this, 6 x 10' of 5"Cr-
loaded K562 cells, were added and after 16 h of incubation, "Cr
released into the medium was determined. Each measurement was
performed in triplicate and the mean value of % specific release
and its standard deviation were calculated. The results shown are
typical of five experiments performed on monocytes of five
different donors.
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Figure 3 Effect of K562 seeding density on monocyte cytotoxi-
city. Experimental conditions were as described in the legend to
Figure 1 except that at time zero varying concentrations of
51Cr-loaded K562 cells were added to wells containing 2 x 105
monocytes. After 16 h culture 5'Cr release was determined. Each
measurement was performed in triplicate and in a, the results are
expressed as c.p.m. released/10' cells with (0) showing the release
by K562 cells alone and (C) the release in K562 cultures
incubated with monocytes. In b, the calculated % specific release
values are shown. Similar results were obtained in six other
experiments with monocytes obtained from separate donors.
increased i.e. under these conditions monocytes exhibited
cytotoxicity towards the K652 cells. However, when
monocytes were added to wells containing <3 x 10' K562
cells, the rate of 51Cr release actually decreased i.e. the
monocytes protected against the high levels of spontaneous
release of 5"Cr from low density K562 cultures. This switch
from tumour cell protection to tumour cell lysis at varying
target cell densities is shown in Figure 3b.
Effects ofmonocytes on 3H-thymidine incorporation by K562
cells
In order to confirm these remarkable observations of tumour
cell protection or destruction by monocytes at different target
cell densities, a second, independent measure of tumour cell
function was assessed. Preliminary experiments revealed that
the amount of 3H-thymidine incorporated into K562 cells
was proportional to the pulse time up to 4 h and also that
under these conditions no incorporation of this compound
into monocytes could be detected: hence, in cultures contain-
ing both monocytes and K562 cells, all of the incorporated
3H-thymidine is attributable to that of the K562 cells. When
incubated in the absence of monocytes, K562 cells at low
seeding densities incorporated relatively low rates of 3H-
thymidine, but as the seeding density increased, so the rate of
incorporation increased (Figure 4a). Thus, at K562 densities
of 3-7 x 104/well, the rate of3H-thymidine incorporation per
cell was fairly constant. When K562 cells at density of
>3 x 104/well co-cultured with monocytes (tumour:
monocyte ratio of 1:<7), the rate of 3H-thymidine incor-
porated/cell was decreased compared with controls (Figure
4a), confirming the results- of the 5"Cr release assay, that
under these conditions monocytes are cytotoxic towards
ov
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Figure 4 Effect of K562 seeding density on 3H-thymidine incor-
poration. Experimental conditions were as described in the legend
to Figure I except that at time zero varying concentrations of
K562 cells were added to wells containing 2 x 105 monocytes.
Suspensions were incubated for 24 h and during the final 2 h
3H-thymidine was added to each well. a, (0) shows incorporation
by K562 cells alone, whereas (0) shows incorporation by K562
cells incubated with monocytes, error bars showing the standard
deviations of triplicate measurements. b, shows these data
represented as % inhibition or (-) stimulation of 3H-thymidine
incorporation. Similar results were obtained in six other
experiments with monocytes from different donors.
K562 cells. However, inclusion of monocytes into K562 cul-
tures of <3 x 104 cells/well (tumour: monocyte ratio of
1:> 7) resulted in an enhancement of 3H-thymidine incor-
poration which was greatest at a K562 cell density of 1 x I04
well (tumour:monocyte ratio of 1:20). Thus, this independent
assay confirms that at low tumour cell densities monocytes
can promote survival and growth, whereas at higher target
cell densities monocytes exert potent cytotoxicity (Figure 4b)
towards the tumour cell target.
Effects of monocytes conditioned medium on K562
In order to assess whether the factor(s) which caused growth
promotion and increased viability of K562 cells was secreted
from monocytes, cell free medium was obtained (conditioned
medium) after culture of monocytes (in the absence of K562
cells) for 24 h. The effects of this conditioned medium on
K562 cells seeded at different densities were then determined.
When K562 cells were seeded at 1 x 104cells/well and cul-
tured alone (Figure 5a), they exhibited low rates of 3H-
thymidine incorporation of 110 c.p.m. (± 12 c.p.m., n = 9).
The inclusion of monocytes into K562 suspensions seeded at
this density (tumour:monocyte ratio of 1:20) resulted in an
increased rate of 3H-thymidine incorporation to 1,773 c.p.m.
(± 777 c.p.m., n = 9), and this effect was mimicked when
monocyte-conditioned medium alone was added to the
tumour cells. When K562 cells were seeded at 6 x 104/well,
they exhibited higher rates of 3H-thymidine incorporation
(Figure 5b) and addition of monocytes at this density
Control Conditioned Monocytes
media
Figure 5 Effect of monocyte-conditioned medium on the incor-
poration of 3H-thymidine by K562 cells. Either 104 (in a) or
6 x I04 (in b) K562 cells were added to wells containing 200 id of
fresh medium (control), 200AI of monocyte-conditioned medium
(obtained after culturing monocytes at 1 x 106 ml- for 24 h in
RPMI medium) or else to wells containing 2 x 105 monocytes in
200 il fresh medium. Experimental conditions were then as de-
scribed in the legend to Figure 4. Similar results were obtained
using conditioned medium from monocytes obtained from four
other donors.
(tumour:monocyte ratio of 1:3) resulted in significant inhibi-
tion of DNA synthesis. However, addition of monocyte-
conditioned medium to K562 cells seeded at this density had
no effect on 3H-thymidine incorporation.
These results clearly show that the factor(s) causing the
enhanced survival and increased growth of low density K562
cultures is endogenously-secreted from monocytes whilst ex-
pression of cytostasis requires an interaction between the
monocytes and tumour targets.
Effects of conditioned media from different cell lines on K562
It was then necessary to determine if conditioned media from
different cell lines could also enhance K562 survival and
growth in a similar way to that obtained from monocytes.
Thus, when K562 cells were seeded at 1 x I04cells/well, the
addition of conditioned media from U937, HL-60 and from
K562 cells all stimulated the rate of 3H-thymidine incorpora-
tion (Figure 6a), but a similar enhancement was not observed
at higher (6 x I04 cells/well) K562 densities (Figure 6b), even
though under these experimental conditions neither 3H-thymi-
dine nor cell density were limiting. It is of interest to note
that none of these conditioned media inhibited the incorpora-
tion of 3H-thymidine.
Conditioned medium from U937, HL 60, HeLa and K562
cells all slightly inhibited the release of 5'Cr from K562 cells
seeded at 1 x I04 cells/well (Figure 7a), but this did not reach
statistical significance. Whilst control values of 5 Cr release
were 173 c.p.m., (± 27 c.p.m., n = 3), this was decreased to
between 144 c.p.m. (± 17 c.p.m.) with medium from HeLa
cells (P <0.2), and 151 c.p.m. (± 10 c.p.m.) with media from
U937 cells (P <0.2). However, when K562 were seeded at
higher cell densities (6 x 104/well), no effect on 5"Cr release
was observed for any conditioned media tested (Figure 7b).
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Figure 6 Effect of conditioned media from continuous cell lines
of 3H-thymidine incorporation. I x 105 U937, HL60 or K562
cells were seeded into U-shaped wells of a microtitre plate in
200 iil culture medium and incubated for 24 h. At the end of this
period the conditioned medium from each of the cell lines was
removed and transferred to new U-shaped wells. To these wells
and also to control wells containing fresh tissue culture medium
104 (in a) or 6 x 104 (in b) K562 cells were added. The cells were
incubated for 24 h with 0.5ftCi 3H-thymidine included for the
last 2 h of incubation. Each measurement was performed in
triplicate and the mean values are plotted with error bars show-
ing the standard deviation of the measurements.
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Effects ofoxidant scavengers on 3H-thymidine incorporation by
K562
Because it has been proposed that tumour cells express low
levels of oxidant scavenging activity (Sun et al., 1989) and
that monocyte-derived oxidants have been implicated as one
mechanism by which these cells kill tumour cells, the effects
of oxidant scavengers on K562 cells were examined. K562
cells seeded at low density incorporated low (256 ± 19c.p.m.)
amounts of 3H-thymidine but his was significantly increased
when either SOD (3413 c.p.m. ± 573, n = 3, P <0.001) or
catalase (4198 c.p.m. ± 592, n = 3, P <0.001) were included
in the suspensions (Figure 8a). When SOD and catalase were
used in combination, no additive effect was observed. When
K562 cells were seeded at higher density (6 x 104/well), they
incorporated 4780 c.p.m. (± 2364, n = 3) and the addition of
SOD and catalase resulted in slight increases in this activity
(Figure 8b), but this did not reach significance (P <0.2).
Heat denatured enzymes (boiled for 30min) had no effect on
the rates of 3H-thymidine incorporation at either K562 cell
density (data not shown). The addition of SOD and catalase
in combination reduced the specific monocyte-dependent cyto-
toxicity (at a K562 seeding density of 6 x 104 cells/well) from
27% (± 4%) to 16% (± 5%) as assessed by 51Cr release
(P <0.05).
Discussion
Whilst it is appreciated that monocytes possess potent
cytotoxicity towards tumour cells, it is also appreciated that
they do not always express such activity. Indeed, the very
fact that many tumours possess large numbers of infiltrating
macrophages (Dougherty & McBride, 1986) is evidence that
this cytotoxic activity in vivo is not always expressed.
Therefore, the identification of the molecular processes which
regulate the development of tumouricidal competence by
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Figure 7 Effect of conditioned media from continuous cell lines
on 51Cr-release from K562 cells 1 x 105 U937, HL60, HeLa or
K562 cells were seeded into U-shaped wells of a microtitre plate
in 200 p1 culture medium and incubated for 24 h. At the end of
this period the conditioned medium from each of the cell lines
was removed and transferred to new U-shaped wells. To these
wells, and also to control wells containing fresh culture medium,
104 (in a) or 6 x 104 (in b) K562 cells loaded with 5'Cr were
added. Each measurement was performed in triplicate, mean
values plotted and error bars show the standard deviation from
the mean.
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Figure 8 Effect of SOD and catalase on 3H-thymidine incorpora-
tion. 104 (in a) or 6 x 104 (in b) K562 cells were seeded into
U-shaped wells of a microtitre plate in 200pA of culture medium.
Immediately after the addition of the cells, superoxide dismutase
(SOD) (40pgml-'), catalase (40 Lgml-') or a combination of
the two were added to the wells. The cells were incubated for
24h and 0.51ACi 3H-thymidine for the last 2h of incubation.
Each measurement was performed in triplicate and the mean
value plotted. Error bars show the standard deviation from the
mean and controls (i.e. no catalase or SOD) were also performed
in triplicate.
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monocytes/macrophages offers the potential of therapeutic
manipulation of these cells as a means of boosting
tumouricidal protection. Murine macrophages (either
resident- or elicited-peritoneal cells) are not spontaneously
cytotoxic unless treated with suitable immuno-modulators
such as y-interferon and LPS (Le & Vilcek, 1984; Schultz &
Kleinschmidt, 1984). However, in the present study we have
shown that freshly-isolated human bloodstream monocytes
exhibit considerable cytotoxicity towards cultured K562 cells
in the absence of exogenously-added immuno-modulating
agents. It may be therefore, that the similarities in function
between murine and human monocytes/macrophages are not
as closely related as is generally assumed.
In order for monocytes to exhibit maximal cytotoxicity
towards the tumour cells, it appears that they must be
incubated as a monolayer. This is presumably because all of
the tumour cells seeded into the monocyte-containing wells
then settle onto an effector cell. Hence, in these experiments
it was essential that monocytes were purified to homogeneity
using Nycodenz so that they could be seeded at confluence at
the bottom of U shaped microtitre wells. When monocytes
were isolated by combined dextran sedimentation/ficoll-
paque centrifugation, an increased cell yield was obtained,
but the suspensions were initially contaminated with lympho-
cytes: when these suspensions were cultured on plastic so that
non-adherent lymphocytes were washed away, the resulting
adherent monocytes were inevitably at non-confluence (Davies,
1991). Physical re-suspension of these adherent monocytes
resulted in gross physical and functional damage and so this
approach to purify monocytes for cytotoxicity assays was
impractical. In all experiments investigating the cytotoxicity
of unperturbed monocytes, it was therefore necessary to
isolate cells to homogeneity by the Nycodenz method.
An important finding of the present study was the observ-
tion that the tumour:monocyte ratio is critical in determining
the outcome of the cellular interactions. Thus, at low
monocyte: K562 cell ratios (3:1), cytotoxicity was observed
and this was detected either as monocyte-dependent release
of 5"Cr or inhibition of DNA synthesis as detected by
measuring 3H-thymidine incorporation. However, at higher
monocyte:tumour ratios (20:1), obtained by maintaining the
monocyte density but decreasing the target density, mono-
cytes actually increased K562 cell survival (as assessed by
decreasing the rate of 51Cr release) and stimulated DNA
synthesis. This phenomenon was, however only observed at
low seeding densities of K562 cells. The factor(s) responsible
for this promotion of tumour growth and viability is
endogenously-secreted from monocytes because it is present
in conditioned medium and it is only effective when the
target tumour cells were seeded at low cell density. It is well
known that cultured cells secrete a variety of growth factors
and other components which promote survival, and that
these never attain sufficiently high concentrations to affect
cell function when cell densities are below a critical level.
Indeed, conditioned medium from several cell lines, including
K562 themselves were also capable or, promoting growth and
survival of low density cultures. We are currently investi-
gating whether the conditioned media from these different
cell lines contains growth-promoting factors which are
similar or distinct from those secreted by monocytes. It is
also necessary to determine if other tumour cells, especially
primary tumour cultures respond in a similar way to K562
cells. Whilst we have used two separate assays to assess
tumour cell physiology, it will also be ofinterest to determine
if other assays of cell proliferation (e.g. clonogenic assays)
parallel our findings.
Levels of oxidant scavenging systems have been reported to
be defective in tumour cells (Sun et al., 1989) and that
reactive oxidants have been implicated in tumouricidal
activity either acting directly or in combination with tumour
necrosis factor (Zimmerman et al., 1989). Indeed, levels of
catalase, glutathione peroxidase and glutathione are reduced
in K562 cells compared with levels in lymphocytes (Stein-
kuhler et al., 1990). We therefore tested the effects of SOD
and catalase on K562 cells. Both SOD and catalase were
found to potentiate DNA synthesis in K562 cells seeded at
low cell densities. This finding suggests that reactive oxidant
species, possibly those generated by the tumour cells
themselves, inhibit the growth and survival of these cells. it is
therefore necessary to determine: (a) if the growth promoting
factor(s) in conditioned media from monocytes and other cell
lines is a growth factor or an antii-oxidant; (b) the role
played by endogenous- and monocyte-derived reactive
oxidants in tumour physiology; (c) whether monocyte-derived
products play a role in enhancing tumour growth and sur-
vival in vivo.
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